Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors.
Sequist LV, Waltman BA, Dias-Santagata D, Digumarthy S, Turke AB, Fidias P, Bergethon K, Shaw AT, Gettinger S, Cosper AK, Akhavanfard S, Heist RS, Temel J, Christensen JG, Wain JC, Lynch TJ, Vernovsky K, Mark EJ, Lanuti M, Iafrate AJ, Mino-Kenudson M, Engelman JA. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med. 2011 Mar 23; 3(75):75ra26.
-
Mari Mino-Kenudson, M.D.
-
Eugene Jerome Mark, M.D.
-
Dora Dias-Santagata, Ph.D.
-
Lecia Vandam Sequist, M.D.
-
Rebecca Suk Heist, M.D.
-
Jennifer Sue Temel, M.D.
-
Subba Rao Digumarthy, M.B.,B.S.
-
Alice Tsang Shaw, Ph.D., M.D.
-
Anthony John Iafrate, M.D.,Ph.D.
-
Michael Lanuti, M.D.